The association of APOE ε4 with cognitive function over the adult life course and incidence of dementia: 20 years follow-up of the Whitehall II study.
Amin Gharbi-MelianiAline DugravotSéverine SabiaMelina RegyAurore FayosseAlexis SchnitzlerMika KivimäkiArchana Singh-ManouxJulien DumurgierPublished in: Alzheimer's research & therapy (2021)
Both heterozygous and homozygous ε4 carriers had poorer cognition and greater risk of dementia at older ages. Our findings show some support for a complex antagonist pleiotropic effect of APOE ε4 heterozygosity over the adult life course, characterized by cognitive advantage in midlife.